Mickael Hiligsmann presented at the World Congress of Osteoporosis 2019
Mickael Hiligsmann co-chaired three symposiums and was speaker at four symposiums during the World Congress of Osteoporosis (WCO-ESCEO-IOF) that was held in Paris between 3 and 6 April 2019.
The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) is a not-for-profit organization, dedicated to a close interaction between clinical scientists dealing with bone, joint and muscle disorder, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of Osteoporosis and Osteoarthritis within the comprehensive perspective of health resources utilization.
The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. – www.esceo.org
Mickael Hiligsmann was invited to chair and speak during the symposium “Selection of relevant outcome in sarcopenia: a discrete-choice experiment” organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) during the International Conference on Frailty & Sarcopenia Research in Miami Beach, USA, on February 22nd, 2019. More information.
Also read
-
Vote for UM Professor Gera Nagelhout as Vrouw in de Media
The Limburg jury of the Vrouw in de Media Award has selected UM professor Gera Nagelhout (CAPHRI) as a nominee for the Vrouw in de Media Award 2025. The award highlights women who, over the past year, have been notably and impactfully visible in the media as experts.
-
Heated tobacco products are not a safe alternative to cigarettes
Heated tobacco products (HTPs) are not a safe alternative to cigarettes, according to recent research by Maastricht University and the Dutch National Institute for Public Health and the Environment (RIVM). Nevertheless, these products are often marketed as less harmful.
-
Science at the frontier of the unknown
How do cancers develop, how do they grow and how does therapy resistance arise? Professor Kasper Rouschop aims to answer these questions.
